Case number 2020-1201
Valeant Pharmaceuticals v. Actavis Laboratories FL., Inc > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | VALEANT PHARMACEUTICALS v. ACTAVIS LABORATORIES FL., INC [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Jan 26, 2021 | 56 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [751890] [MJL] [Entered: 01/26/2021 04:25 PM] (2) |
| Dec 30, 2020 | 55 | Bill of Costs for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/30/2020 by email. [746005] [20-1201] [William Jay] [Entered: 12/30/2020 12:15 PM] (1) |
| Dec 18, 2020 | 54 | JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [743677] [JAB] [Entered: 12/18/2020 09:18 AM] (2) |
| Dec 9, 2020 | 53 | Submitted after ORAL ARGUMENT to Panel: Newman, Circuit Judge; Dyk, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: Thomas P. Steindler for Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited and William M. Jay for Teva Pharmaceuticals USA, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Actavis Laboratories FL., Inc.Oral Argument Audio available here. [741411] [JAB] [Entered: 12/09/2020 12:10 PM] (0) |
| Nov 19, 2020 | 52 | Clerk's letter to Appellants Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., Valeant Pharmaceuticals International and Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [736910] [JAB] [Entered: 11/19/2020 11:59 AM] (0) |
| Nov 12, 2020 | 51 | Response to notice of oral argument from Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 11/12/2020 by email. [735049] [20-1201] [William Jay] [Entered: 11/12/2020 11:26 AM] (1) |
| Nov 12, 2020 | 50 | Response to notice of oral argument from Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited. Service: 11/12/2020 by email. [735027] [20-1201]--[Edited 11/16/2020 by JAB to correct filers] [Thomas Steindler] [Entered: 11/12/2020 10:45 AM] (1) |
| Oct 21, 2020 | 49 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2012I. Case scheduled December 9, 2020. Response to Notice of Oral Argument due: 11/16/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [730602] [JAB] [Entered: 10/21/2020 02:42 PM] (1) |
| Aug 31, 2020 | 48 | 6 paper copies of the Response Brief [32] received from Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. [727495] [JCP] [Entered: 10/07/2020 05:02 PM] (0) |
| Aug 27, 2020 | 46 | The following conflict dates submitted by Thomas P. Steindler for Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd. have been accepted by the court: 03/01/2021, 03/02/2021, 03/03/2021, 03/04/2021, 03/05/2021. [717899] [JAB] [Entered: 08/27/2020 09:10 AM] (0) |
| Aug 26, 2020 | 45 | Notice from Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited regarding conflicts with oral argument. Service: 08/26/2020 by email. [717840] [20-1201] [Paul Devinsky] [Entered: 08/26/2020 06:04 PM] (4) |
| Aug 25, 2020 | 47 | 6 paper copies of Doc. Nos. [24], [37], [39] received from Cosmo Technologies Limited, Salix Pharmaceuticals Ltd. and Valeant Pharmaceuticals International. [722395] [MJL] [Entered: 09/17/2020 10:18 AM] (0) |
| Aug 25, 2020 | 44 | Notice from Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument. None. Service: 08/25/2020 by email. [717490] [20-1201] [William Jay] [Entered: 08/25/2020 04:05 PM] (1) |
| Aug 20, 2020 | 43 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [716380] [MMA] [Entered: 08/20/2020 07:18 PM] (1) |
| Aug 20, 2020 | 42 | Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before August 3, 2020. See Administrative Order No. 20-01 (Mar. 20, 2020). [716373] [MMA] [Entered: 08/20/2020 06:58 PM] (0) |
| Aug 12, 2020 | 41 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd., Cosmo Technologies Limited and Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/12/2020 by email. [714533] [20-1201] [Thomas Steindler] [Entered: 08/12/2020 06:13 PM] (4) |
| Aug 12, 2020 | 40 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited. Service: 08/12/2020 by email. [714532] [20-1201] [Thomas Steindler] [Entered: 08/12/2020 06:11 PM] (3) |
| Aug 12, 2020 | 39 | MODIFIED ENTRY: APPENDIX FILED for Appellants Cosmo Technologies Limited, Salix Pharmaceuticals Ltd. and Valeant Pharmaceuticals International. Number of Pages: 441. Service: 08/12/2020 by email. [714529]--[Edited 08/20/2020 by MMA - Reason: compliance review complete] [Thomas Steindler] [Entered: 08/12/2020 06:09 PM] (441) |
| Aug 12, 2020 | 38 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 08/12/2020 by email. [714511] [20-1201] [William Jay] [Entered: 08/12/2020 04:48 PM] (3) |
| Aug 5, 2020 | 37 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Cosmo Technologies Limited, Salix Pharmaceuticals Ltd. and Valeant Pharmaceuticals International. Number of Pages: 30. Service: 08/05/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [712824]--[Edited 08/12/2020 by MMA - Reason: compliance review complete] [Thomas Steindler] [Entered: 08/05/2020 04:39 PM] (40) |
| Aug 4, 2020 | 36 | Amended Certificate of Interest for Appellant Cosmo Technologies Limited. Service: 08/04/2020 by email. [712551] [20-1201] [Gary Frischling] [Entered: 08/04/2020 07:12 PM] (2) |
| Aug 4, 2020 | 35 | Amended Certificate of Interest for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 08/04/2020 by email. [712470] [20-1201] [Thomas Steindler] [Entered: 08/04/2020 03:57 PM] (2) |
| Jun 19, 2020 | 34 | **TEXT ONLY** ORDER granting motion to extend time to file brief [33] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Salix Pharmaceuticals Ltd. The reply brief is due 08/05/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [702597] [MMA] [Entered: 06/19/2020 05:45 PM] (0) |
| Jun 18, 2020 | 33 | MOTION of Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited to extend the time to 08/05/2020 to file the Appellants' Reply Brief. [Consent: unopposed]. Service: 06/18/2020 by email. [702237] [20-1201] [Thomas Steindler] [Entered: 06/18/2020 02:56 PM] (11) |
| Jun 12, 2020 | 32 | MODIFIED ENTRY: BRIEF FILED for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. Number of Pages: 56. Service: 06/12/2020 by email. [700949]--[Edited 06/22/2020 by MMA - Reason: compliance review complete] [William Jay] [Entered: 06/12/2020 08:57 PM] (67) |
| May 4, 2020 | 31 | **TEXT ONLY** ORDER granting motion to withdraw attorney Joshua J. Bone [29] filed by Appellees Teva Pharmaceuticals USA, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Actavis Laboratories FL., Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [692115] [MMA] [Entered: 05/04/2020 05:50 PM] (0) |
| May 4, 2020 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file brief [28] filed by Appellees Teva Pharmaceuticals USA, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Actavis Laboratories FL., Inc. The response brief is due 06/12/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [692106] [MMA] [Entered: 05/04/2020 05:39 PM] (0) |
| May 1, 2020 | 29 | MOTION of Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. to withdraw counsel Joshua J. Bone [Consent: unopposed]. Service: 05/01/2020 by email. [691796] [20-1201] [William Jay] [Entered: 05/01/2020 06:40 PM] (6) |
| May 1, 2020 | 28 | MOTION of Appellees Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. and Actavis Laboratories FL., Inc. to extend the time to 06/12/2020 to file the response brief. [Consent: unopposed]. Service: 05/01/2020 by email. [691709] [20-1201] [William Jay] [Entered: 05/01/2020 03:07 PM] (8) |
| May 1, 2020 | 27 | Entry of appearance for Gerard J. Cedrone as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 05/01/2020 by email. [691701] [20-1201] [Gerard Cedrone] [Entered: 05/01/2020 03:00 PM] (2) |
| Apr 2, 2020 | 26 | **TEXT ONLY** ORDER granting motion to extend time to file brief [25] filed by Appellees Teva Pharmaceuticals USA, Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Actavis Laboratories FL., Inc. The response brief is due 05/13/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [683715] [MMA] [Entered: 04/02/2020 12:00 PM] (0) |
| Apr 1, 2020 | 25 | MOTION of Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. to extend the time to 05/13/2020 to file the response brief. [Consent: unopposed]. Service: 04/01/2020 by email. [683474] [20-1201] [William Jay] [Entered: 04/01/2020 01:58 PM] (8) |
| Mar 24, 2020 | 24 | MODIFIED ENTRY: CORRECTED BRIEF FILED for Appellants Cosmo Technologies Limited, Salix Pharmaceuticals Ltd. and Valeant Pharmaceuticals International. Number of Pages: 39. Service: 03/24/2020 by email. [681353]--[Edited 04/02/2020 by MMA - Reason: compliance review complete] [Thomas Steindler] [Entered: 03/24/2020 12:19 PM] (118) |
| Mar 23, 2020 | 23 | Corrected Certificate of Interest for Appellant Cosmo Technologies Limited. Service: 03/23/2020 by email. [681195] [20-1201] [Gary Frischling] [Entered: 03/23/2020 11:03 PM] (3) |
| Mar 18, 2020 | 22 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Cosmo Technologies Limited, Salix Pharmaceuticals Ltd., and Valeant Pharmaceuticals International, Opening Brief [20], is not in compliance with the rules of this court (see attached). Compliant document is due on 03/25/2020. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [679665] [JAL] [Entered: 03/18/2020 07:54 AM] (2) |
| Mar 18, 2020 | 21 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [679664] [JAL] [Entered: 03/18/2020 07:42 AM] (0) |
| Mar 4, 2020 | 20 | FILED from Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited. Title: OPENING BRIEF. Service: 03/04/2020 by email. [676322] [20-1201] This document is non-compliant. See Doc No.[22] [Thomas Steindler] [Entered: 03/04/2020 03:14 PM] (118) |
| Feb 3, 2020 | 19 | Entry of appearance for Samuel E. Sherry as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 02/03/2020 by email. [667881] [20-1201] [Samuel Sherry] [Entered: 02/03/2020 10:58 AM] (2) |
| Jan 28, 2020 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file Appellants' opening brief [17] filed by Appellants Valeant Pharmaceuticals International, Cosmo Technologies Limited and Salix Pharmaceuticals Ltd. The opening brief is due 03/04/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [666506] [TAM] [Entered: 01/28/2020 01:20 PM] (0) |
| Jan 24, 2020 | 17 | MOTION of Appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. and Cosmo Technologies Limited to extend the time to 03/04/2020 to file the Appellants' Opening Brief due 02/03/2020. [Consent: unopposed]. Service: 01/24/2020 by email. [665969] [20-1201] [Thomas Steindler] [Entered: 01/24/2020 04:39 PM] (11) |
| Dec 18, 2019 | 16 | Entry of appearance for Yite John Lu as of counsel for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657680] [20-1201] [Yite Lu] [Entered: 12/18/2019 06:24 PM] (2) |
| Dec 18, 2019 | 15 | Docketing Statement for the Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657679] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:19 PM] (3) |
| Dec 18, 2019 | 14 | Certificate of Interest for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657677] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:18 PM] (3) |
| Dec 18, 2019 | 13 | Entry of appearance for Gary Frischling as principal counsel for Appellant Cosmo Technologies Limited. Service: 12/18/2019 by email. [657675] [20-1201] [Gary Frischling] [Entered: 12/18/2019 06:16 PM] (2) |
| Dec 18, 2019 | 12 | Entry of appearance for Christopher M. Bruno as of counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657628] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:09 PM] (2) |
| Dec 18, 2019 | 11 | Entry of appearance for Paul M. Schoenhard as of counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657626] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:08 PM] (2) |
| Dec 18, 2019 | 10 | Docketing Statement for the Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657624] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:06 PM] (4) |
| Dec 18, 2019 | 9 | Certificate of Interest for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657623] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:05 PM] (3) |
| Dec 18, 2019 | 8 | Entry of appearance for Thomas P. Steindler as principal counsel for Appellants Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd.. Service: 12/18/2019 by email. [657618] [20-1201] [Thomas Steindler] [Entered: 12/18/2019 04:03 PM] (2) |
| Dec 18, 2019 | 7 | Entry of appearance for Joshua James Bone as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657528] [20-1201] [Joshua Bone] [Entered: 12/18/2019 12:56 PM] (2) |
| Dec 18, 2019 | 6 | Entry of appearance for John T. Bennett as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657524] [20-1201] [John Bennett] [Entered: 12/18/2019 12:54 PM] (2) |
| Dec 18, 2019 | 5 | Entry of appearance for Elizabeth J. Holland as of counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657522] [20-1201] [Elizabeth Holland] [Entered: 12/18/2019 12:52 PM] (2) |
| Dec 18, 2019 | 4 | Certificate of Interest for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657519] [20-1201] [William Jay] [Entered: 12/18/2019 12:49 PM] (3) |
| Dec 18, 2019 | 3 | Docketing Statement for the Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657518] [20-1201] [William Jay] [Entered: 12/18/2019 12:48 PM] (4) |
| Dec 18, 2019 | 2 | Entry of appearance for William M. Jay as principal counsel for Appellees Actavis Laboratories FL., Inc., Actavis Pharma, Inc., Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc.. Service: 12/18/2019 by email. [657488] [20-1201] [William Jay] [Entered: 12/18/2019 12:06 PM] (2) |
| Dec 4, 2019 | 1 | Appeal docketed. Received: 11/22/2019. [653858]Entry of Appearance due 12/18/2019. Certificate of Interest is due on 12/18/2019. Docketing Statement due 12/18/2019. Appellant's brief is due 02/03/2020. [TAM] [Entered: 12/04/2019 09:21 AM] (48) |
